definiens: shall mean a recombinant DNA - derived fusion protein containing ( a ) a human papilloma virus ( HPV ) type-16 E7 antigen, antigenic fragment or conjugate thereof and ( b ) a bacterial stress protein, including without limitation, a bacterial stress protein derived from the 65kDa heat shock protein of Mycoba ~ terium bovis var . BeG 3 ( Hsp65 ), where such bacterial stress protein is coupled at the C - terminus to the E7 protein of the HPV type 16, 1,12 shall mean an application to the FDA, the filing of which is necessary to commence clinical testing of Target Products in humans, or the equivalent application to the equivalent agency in any other country or group of countries, 1.13 shall mean any invention or discovery, whether or not patentable, made as a result of activities of a Party or the Parties pursuant to this Agreement, and which relates to a Target Product . An may be made by employees of Stressgen or SBC solely or jointly with a Third Party ( a ), by employees of [COMPANY] solely or jointly with a Third Party ( a ), or jointly by employees of Stressgen or SBC and [COMPANY] with or without a Third Party ( a ), in each instance as determined by U, S, laws of inventorship, 1.14 shall mean that certain License Agreement dated November 3, 1992 between Massachusetts Institute of Technology and the Whitehead Institute ( collectively ) and SBC, as amended, 1.15 shall mean the GW Indication limited to treating na'ive patients having warts that have had no prior drug, ablative or surgical treatment